What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes.
Amputation
Brachytherapy
External beam radiation
Laser
Moh’s micrographic surgery
Penile cancer
Penile sparing
Psychological well-being
Quality of life
Recurrence
Sexual function
Surgery
Journal
European urology open science
ISSN: 2666-1683
Titre abrégé: Eur Urol Open Sci
Pays: Netherlands
ID NLM: 101771568
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
accepted:
06
04
2022
entrez:
11
5
2022
pubmed:
12
5
2022
medline:
12
5
2022
Statut:
epublish
Résumé
The primary lesion in penile cancer is managed by surgery or radiation. Surgical options include penile-sparing surgery, amputative surgery, laser excision, and Moh's micrographic surgery. Radiation is applied as external beam radiotherapy (EBRT) and brachytherapy. The treatment aims to completely remove the primary lesion and preserve a sufficient functional penile stump. To assess whether the 5-yr recurrence-free rate and other outcomes, such as sexual function, quality of life, urination, and penile preserving length, vary between various treatment options. The EMBASE, MEDLINE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials (CENTRAL; Cochrane HTA, DARE, HEED), Google Scholar, and ClinicalTrials.gov were searched for publications from 1990 through May 2021. Randomized controlled trials, nonrandomized comparative studies (NRCSs), and case series (CSs) were included. The systematic review included 88 studies, involving 9578 men from 16 NRCSs and 72 CSs. The cumulative mean 5-yr recurrence-free rates were 82.0% for penile-sparing surgery, 83.9% for amputative surgery, 78.6% for brachytherapy, 55.2% for EBRT, 69.4% for lasers, and 88.2% for Moh's micrographic surgery, as reported from CSs, and 76.7% for penile-sparing surgery and 93.3% for amputative surgery, as reported from NRCSs. Penile surgery affects sexual function, but amputative surgery causes more appearance concerns. After brachytherapy, 25% of patients reported sexual dysfunction. Both penile-sparing surgery and amputative surgery affect all aspects of psychosocial well-being. Despite the poor quality of evidence, data suggest that penile-sparing surgery is not inferior to amputative surgery in terms of recurrence rates in selected patients. Based on the available information, however, broadly applicable recommendations cannot be made; appropriate patient selection accounts for the relative success of all the available methods. We reviewed the evidence of various techniques to treat penile tumor and assessed their effectiveness in oncologic control and their functional outcomes. Penile-sparing as well as amputative surgery is an effective treatment option, but amputative surgery has a negative impact on sexual function. Penile-sparing surgery and radiotherapy are associated with a higher risk of local recurrence, but preserve sexual function and quality of life better. Laser and Moh's micrographic surgery could be used for smaller lesions.
Identifiants
pubmed: 35540709
doi: 10.1016/j.euros.2022.04.002
pii: S2666-1683(22)00077-5
pmc: PMC9079254
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
58-94Informations de copyright
© 2022 The Authors.
Références
BJU Int. 2004 Dec;94(9):1253-7
pubmed: 15610100
BJU Int. 2018 Oct;122(4):576-582
pubmed: 29604228
Cancer. 2008 Nov 15;113(10 Suppl):2883-91
pubmed: 18980292
Clin Genitourin Cancer. 2018 Dec;16(6):e1215-e1220
pubmed: 30201215
J Surg Oncol. 2008 May 1;97(6):487-95
pubmed: 18425779
Urology. 2007 Apr;69(4):759-62
pubmed: 17445665
Strahlenther Onkol. 1999 Jan;175(1):17-20
pubmed: 9951513
Eur J Oncol Nurs. 2017 Dec;31:1-5
pubmed: 29173821
J Urol. 2012 Sep;188(3):803-8
pubmed: 22818137
Br J Urol. 1994 Nov;74(5):652-7
pubmed: 7827818
J Urol. 2003 Jun;169(6):2118-21
pubmed: 12771731
Br J Urol. 1994 May;73(5):554-60
pubmed: 8012779
World J Urol. 2018 Feb;36(2):265-270
pubmed: 29197968
Urology. 2020 Aug;142:161-165.e1
pubmed: 32380155
Eur J Cancer. 2013 Apr;49(6):1414-21
pubmed: 23231984
Urol Int. 2000;65(3):130-4
pubmed: 11054029
Brachytherapy. 2015 Jul-Aug;14(4):525-30
pubmed: 25863414
Int J Radiat Oncol Biol Phys. 1992;24(3):479-83
pubmed: 1399733
Urology. 2020 Nov;145:281-286
pubmed: 32683069
J Urol. 2011 Oct;186(4):1303-7
pubmed: 21862071
Urol Oncol. 2007 Sep-Oct;25(5):361-7
pubmed: 17826651
J Am Acad Dermatol. 2021 Apr;84(4):1030-1036
pubmed: 33279645
Urol Int. 1999;62(4):234-7
pubmed: 10567891
Urol Oncol. 2018 Apr;36(4):147-152
pubmed: 29097087
Oncology. 1997 Jan-Feb;54(1):23-7
pubmed: 8978588
BJU Int. 2010 Sep;106(6):786-90
pubmed: 20089106
Can Urol Assoc J. 2015 Jul-Aug;9(7-8):E423-7
pubmed: 26279710
Oncotarget. 2017 Jun 28;8(59):100469-100477
pubmed: 29245993
Eur Urol. 2007 Oct;52(4):1179-85
pubmed: 17349734
Eur Urol. 2008 Sep;54(3):631-9
pubmed: 18788122
Urology. 2005 Dec;66(6):1292-5
pubmed: 16360459
World J Urol. 2009 Apr;27(2):189-96
pubmed: 18636264
Brachytherapy. 2018 Jan - Feb;17(1):221-226
pubmed: 29089276
Eur Urol. 2008 Oct;54(4):875-82
pubmed: 18243513
Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1150-6
pubmed: 19395183
Int Braz J Urol. 2021 May-Jun;47(3):515-522
pubmed: 33620995
World J Urol. 2004 Apr;22(1):60-6
pubmed: 14657999
Eur Urol. 2018 Feb;73(2):284-289
pubmed: 27746062
Urol Oncol. 2021 May;39(5):302.e19-302.e27
pubmed: 33612354
Eur J Surg Oncol. 2018 Sep;44(9):1425-1431
pubmed: 29656798
Radiat Oncol. 2016 Jul 27;11:96
pubmed: 27464910
South Med J. 2002 Aug;95(8):822-5
pubmed: 12190215
BJU Int. 2007 Dec;100(6):1277-81
pubmed: 17850372
Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):674-9
pubmed: 16949770
Urol Oncol. 2011 Nov-Dec;29(6):782-7
pubmed: 19945307
Eur Urol. 1997;31(3):339-42
pubmed: 9129927
Eur J Cancer. 2001 Jan;37(2):198-203
pubmed: 11166146
J Urol. 2014 Nov;192(5):1410-7
pubmed: 24769027
Can Urol Assoc J. 2021 Jun;15(6):187-191
pubmed: 33212003
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Urol Oncol. 2018 Apr;36(4):141-146
pubmed: 28882673
J Urol. 2003 Feb;169(2):500-2
pubmed: 12544296
World J Surg Oncol. 2015 Feb 22;13:71
pubmed: 25889238
Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):563-570
pubmed: 28501419
J Urol. 2014 Jul;192(1):120-5
pubmed: 24373799
Adv Urol. 2011;2011:240824
pubmed: 21603193
Andrology. 2014 Sep;2(5):729-33
pubmed: 24923484
J Urol. 2017 May;197(5):1258-1263
pubmed: 28027867
Sex Health. 2019 Feb;16(1):32-38
pubmed: 30532994
Asian J Androl. 2017 Jan-Feb;19(1):57-61
pubmed: 26643562
Radiother Oncol. 1995 Aug;36(2):83-93
pubmed: 7501816
Can J Urol. 2014 Apr;21(2):7201-6
pubmed: 24775572
Clin Oncol (R Coll Radiol). 2000;12(1):25-31
pubmed: 10749016
World J Urol. 2020 Feb;38(2):417-424
pubmed: 31062123
Indian J Urol. 2013 Apr;29(2):119-23
pubmed: 23956513
Clin Transl Radiat Oncol. 2021 Jan 17;27:89-95
pubmed: 33537466
BJU Int. 2012 Dec;110(11):1792-5
pubmed: 22551234
Clin Oncol (R Coll Radiol). 2006 May;18(4):320-5
pubmed: 16703750
J Urol. 2007 Nov;178(5):1980-5
pubmed: 17869306
Urology. 1998 Oct;52(4):559-65
pubmed: 9763071
Eur Urol. 2008 Jul;54(1):161-8
pubmed: 18440124
Urology. 2015 May;85(5):1097-1103
pubmed: 25769781
Asian J Surg. 2007 Apr;30(2):126-30
pubmed: 17475583
Brachytherapy. 2014 Jul-Aug;13(4):380-7
pubmed: 23896397
Eur Urol. 2000 Sep;38(3):306-12
pubmed: 10940705
Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):460-7
pubmed: 15890588
BJU Int. 2005 Nov;96(7):1040-3
pubmed: 16225525
J Urol. 2014 Oct;192(4):1105-10
pubmed: 24747092
Eur Urol. 2018 Feb;73(2):290-300
pubmed: 28917594
Dermatol Surg. 2016 Aug;42(8):936-44
pubmed: 27467227
Brachytherapy. 2015 Jul-Aug;14(4):517-24
pubmed: 25944394
Urology. 2021 Jun;152:60-66
pubmed: 33600836
J Contemp Brachytherapy. 2010 Dec;2(4):157-159
pubmed: 27853477
Urologe A. 2018 Apr;57(4):444-452
pubmed: 29476193
J Urol. 2017 Oct;198(4):770-779
pubmed: 28286072
J Urol. 2018 May;199(5):1233-1237
pubmed: 29132984
Sci Rep. 2016 Feb 23;6:21862
pubmed: 26902397
Arab J Urol. 2011 Jun;9(2):115-20
pubmed: 26579279
BMC Urol. 2009 Aug 08;9:8
pubmed: 19664235
Urology. 2011 Nov;78(5):1121-4
pubmed: 22054385
Int J Radiat Oncol Biol Phys. 1993 Mar 15;25(4):623-8
pubmed: 8454480
J Urol. 2004 Aug;172(2):648-51
pubmed: 15247753
Clin Oncol (R Coll Radiol). 2015 Jul;27(7):387-93
pubmed: 26003455
BJU Int. 2021 May;127(5):606-613
pubmed: 33180969
Int J Impot Res. 2009 Sep-Oct;21(5):311-4
pubmed: 19458620
Urology. 2017 Nov;109:140-144
pubmed: 28818536
Brachytherapy. 2019 Jul - Aug;18(4):493-502
pubmed: 31101437
J Urol. 2006 Aug;176(2):575-80; discussion 580
pubmed: 16813892